Abstract
A review of what is presently known about the G protein-coupled receptor GPR18, which activated by the phytocannabinoid Δ9-tetrahydrocannabinol (Δ9-THC) and N-arachidonoyl glycine (NAGly) by an oxygenated metabolite of the endogenous cannabinoid anandamide (AEA). The review will outline what is known about this receptor, the ligands that activate and block the receptor, and how these interactions fit within cannabinoid/endocannabinoid signaling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aneetha H, O’Dell DK, Tan B, Walker JM, Hurley TD (2009) Alcohol dehydrogenase-catalyzed in vitro oxidation of anandamide to N-arachidonoyl glycine, a lipid mediator: synthesis of N-acyl glycinals. Bioorg Med Chem Lett 19(1):237–241
Ballesteros JA, Weinstein H, Stuart CS (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. In: Sealfon SC (ed) Methods in neurosciences, vol 25. Academic, San Diego, pp 366–428
Begg M, Pacher P, Bátkai S, Osei-Hyiaman D, Offertáler L, Mo FM, Liu J, Kunos G (2005) Evidence for novel cannabinoid receptors. Pharmacol Ther 106(2):133–145
Bockaert J, Philippe Pin J (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18(7):1723–1729
Bradshaw H, Rimmerman N, Hu S, Benton V, Stuart J, Masuda K, Cravatt B, O’Dell D, Walker JM (2009) The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem 10(1):14
Devane WA (1999) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 252:946–1949
Franklin A, Stella N (2003) Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 474(2–3):195–198
Gantz I, Muraoka A, Yang Y-K, Samuelson LC, Zimmerman EM, Cook H, Yamada T (1997) Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis. Genomics 42(3):462–466
Horn F, Weare J, Beukers MW, Hörsch S, Bairoch A, Chen W, Edvardsen O, Campagne F, Vriend G (1998) GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res 26(1):275–279
Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E et al (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci 96(24): 14136–14141
Kohno M, Hasegawa H, Inoue A, Muraoka M, Miyazaki T, Oka K, Yasukawa M (2006) Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18. Biochem Biophys Res Commun 347(3):827–832
Ls O, Mo F-M, Sn B, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G (2003) Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63(3):699–705
Mackie K, Stella N (2006) Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 8(2):E298–E306
McHugh D, Hu S, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw H (2010) N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 11(1):44
McHugh D, Page J, Bradshaw H (2012b) siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates the cell migration induced by N-arachidonoyl glycine. In: The 21st annual symposium of the International Cannabinoid Research Society, pp 2–3
McHugh D, Page J, Dunn E, Bradshaw HB (2012) Delta(9)-THC and N-arachidonyl glycine are full agonists at GPR18 and cause migration in the human endometrial cell line, HEC-1B. Br J Pharmacol 165(8):2414–2424
Mechoulam R, Gaoni Y (1965) A total synthesis of Dl-delta-1-tetrahydrocannabinol, the active constituent of Hashish. J Am Chem Soc 87:3273–3275
Mo FM, Offertáler L, Kunos G (2004) Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur J Pharmacol 489(1–2):21–27
Petroff OA (2002) GABA and glutamate in the human brain. Neuroscientist 8(6):562–573
Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol Rev 62:588–631
Qin Y, Verdegaal EME, Siderius M, Bebelman JP, Smit MJ, Leurs R, Willemze R, Tensen CP, Osanto S (2011) Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell Melanoma Res 24(1):207–218
Rosenkilde MM, Benned-Jensen T, Andersen H, Holst PJ, Kledal TN, Luttichau HR, Larsen JK, Geisler C, Christensen JP, Schwartz TW (2006) Molecular pharmacological phenotyping of EBI2—an orphan 7TM receptor with constitutive activity. J Biol Chem 281(19):13199–13208
Vaccani A, Massi P, Colombo A, Rubino T, Parolaro D (2005) Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism. Br J Pharmacol 144(8):1032–1036
Vassilatis DK, Hohmann JG, Zeng H, Li F, Ranchalis JE, Mortrud MT, Brown A, Rodriguez SS, Weller JR, Wright AC et al (2003) The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci 100(8):4903–4908
Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23(4):1398–1405
(2010) Themed issue on cannabinoids. Br J Pharmacol 160:1–783
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
McHugh, D., Bradshaw, H.B. (2013). GPR18 and NAGly Signaling: New Members of the Endocannabinoid Family or Distant Cousins?. In: Abood, M., Sorensen, R., Stella, N. (eds) endoCANNABINOIDS. The Receptors, vol 24. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4669-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4669-9_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4668-2
Online ISBN: 978-1-4614-4669-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)